We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
You are on page 1/ 1
ICH Ref No.| Topic & title ‘Subtopic Title / Topie Description
‘OIA [Siailiy Testing of New Drug Substance & Products
1B [Photontabilty Tesiug of New dug Substance & producte
w easy OC _|Siabiliy Testing for New Dosage Forms
‘QI [Bracketing & Matrixing Design fr stability testing of New Drag Substance & Products
QUE [Evaluation of Stability Data
QL __| Stability Dain pockage for Regisvation applications in Climate Zone Ml & IV = Witham
(G2__[Analyieal Vaidaion| | Valdation of Anabicl Procedure = Text & Methodoly
GBA [impunties in New Drug Substance
Q3B [Impurities im New Drug Products
co) Impurities | ~O3C | Guideines for Residual Solvents
Q3D_| Guidelines for Eemeatal Impurities
‘Q3E__|Assessment& Coutol ofFxtracables & Jenchables for Pharmacutieas & Biologics
‘Q4A_|Pharmacopocial Hormenisation
24 _|_ Pharmacopocias [Qa [Evaluation & recommendation of Panaacopactal ew Tore fx ICH resons
‘Q5A _| Vil Safety Fvalution of Biotechnology Products dereived fiom Cell ines of una or aia ota
Quilty of | O38 [Analysis of te expression Coustct in cells used for production of RNA derived protei products
05 | Biotecinologil | —O5C | Quality of Biotechnology Produets - stabil testing of bioteechnolgial/ bilogiea products
rodeuts (Q5D_[Desivtion & Chrsctezaiono cll batts used for production of biotechnological products
Q5E_ | Compartiliy of biotechnological bologial products subject fo change in mannfactting process
o Pea ‘Q6A | Test Procedure & Acceptance Criteria for New Drug Substance & Products: Chemieal Substances
ations | Q6B [Test Procedure & Acceptance Criteria for Botechacogical/Bilogieal Prodeuls
a GMP = [Good Manufacturing Practise Guide for Active Pharmaceutical lagredients
Os PD = _[Pharmscseutial Development
co “ORM = [Quality Risk Management
Quo POS =| Pharmaceatial Quality System
Development &
Qt |atanufacture of Drug] - | Development & Manufacture of Drug Substance - (Chemical Entities and Bioteechnoloical/ Biological
Substance cites
a2 ae «| Fectnicsl& Reyuatory Consideration of Pharmacewseal Product Life Cyole Management
Continous 5
as Mate | _-_ [Contin niauticnsing of Dmg Sutnces nd Dr Prodts
ais [Ansel Procedure) _ | auatyical Procedure development & Revision of Q2 - Analytical Validation
Development